18 PRIMECAP Management Allogene Therapeutics Trades
PRIMECAP Management acquired 4.93 Million Allogene Therapeutics shares worth $5.72 Million. That's 0.00% of their equity portfolio (265th largest holding). The investor owns 2.26% of the outstanding Allogene Therapeutics stock. The first Allogene Therapeutics trade was made in Q4 2020. Since then PRIMECAP Management bought shares eleven more times and sold shares on six occasions. The investor's estimated purchase price is $109 Million, resulting in a loss of 95%.
Avg closing price
Price range
Increased shares by 0.1% (+4.5 Thousand shares)
Q1 2025
Avg closing price
$1.89
Price range
$1.40
-
$2.84
Sold 13.1% shares (-741 Thousand shares)
Q4 2024
Avg closing price
$2.46
Price range
$1.86
-
$3.22
Sold 0.0% shares (-1.97 Thousand shares)
Q3 2024
Avg closing price
$2.66
Price range
$2.08
-
$3.50
Increased shares by 4.1% (+222 Thousand shares)
Q2 2024
Avg closing price
$2.95
Price range
$2.23
-
$4.38
Increased shares by 3.2% (+167 Thousand shares)
Q1 2024
Avg closing price
$4.17
Price range
$2.92
-
$5.63
Sold 0.0% shares (-2.5 Thousand shares)
Q4 2023
Avg closing price
$2.84
Price range
$2.28
-
$3.50
Sold 6.3% shares (-352 Thousand shares)
Q3 2023
Avg closing price
$4.38
Price range
$3.17
-
$5.96
Sold 2.3% shares (-132 Thousand shares)
Q2 2023
Avg closing price
$5.41
Price range
$4.53
-
$6.74
Increased shares by 16.7% (+825 Thousand shares)
Q1 2023
Avg closing price
$6.41
Price range
$4.92
-
$8.21
Increased shares by 1.0% (+51.1 Thousand shares)
Q4 2022
Avg closing price
$9.26
Price range
$5.62
-
$11.11
Increased shares by 0.2% (+9.9 Thousand shares)
Q3 2022
Avg closing price
$13.59
Price range
$10.32
-
$17.28
Sold 0.5% shares (-23.3 Thousand shares)
Q2 2022
Avg closing price
$8.88
Price range
$6.78
-
$12.28
Increased shares by 5.2% (+244 Thousand shares)
Q1 2022
Avg closing price
$10.42
Price range
$7.65
-
$15.29
Increased shares by 29.3% (+1.06 Million shares)
Q4 2021
Avg closing price
$17.64
Price range
$13.13
-
$24.52
Increased shares by 0.8% (+27.3 Thousand shares)
Q3 2021
Avg closing price
$23.74
Price range
$21.01
-
$27.64
Increased shares by 174.0% (+2.27 Million shares)
Q2 2021
Avg closing price
$28.52
Price range
$23.49
-
$35.80
Increased shares by 5.4% (+67 Thousand shares)
Q1 2021
Avg closing price
$33.73
Price range
$25.79
-
$39.02
New holding (+1.24 Million shares)
Q4 2020
Avg closing price
$32.59
Price range
$25.24
-
$43.45
